Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers

Clinical trial NCT07686367 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07686367
Sponsor: National Cancer Institute (NCI)
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Myxoid Liposarcoma Metastatic Synovial Sarcoma Unresectable Myxoid Liposarcoma Unresectable Synovial Sarcoma

Start date: 2026-09-11
Primary completion: 2027-11-30
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.